Home › Atrial Fibrillation › Florida › Pensacola
Atrial Fibrillation clinical trials in Pensacola, FL
5 studies for Atrial Fibrillation are looking for participants at sites in and around Pensacola (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
RecruitingPhase 3
- Sec Clinical Research, Pensacola
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Ascension Sacred Heart, Pensacola
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
RecruitingPhase 3
- Sec Clinical Research, Pensacola
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthis Investigational site 9811, Pensacola
- Anthos Investigational site9830, Pensacola
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Ascension Sacred Heart Pensacola, Pensacola
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Pensacola
- Heart Failure6 studies
- Obesity6 studies
- Cardiovascular Disease5 studies
- Macular Degeneration5 studies
- Burkitt Lymphoma4 studies
- Overweight4 studies
- Acute Biphenotypic Leukemia3 studies
- Acute Myeloid Leukemia3 studies
- Crohn's Disease3 studies
- Ulcerative Colitis3 studies
- Non-Small Cell Lung Cancer3 studies
- Geographic Atrophy3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.